Liver Cirrhosis: all 1,668 studies
Page 8 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- Effect of Imatinib in Advance Liver Fibrosis PatientsStatus unknownNCT05224128Phase 1/2
- Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouchCompletedNCT05224037Not applicable
- Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet StudyStatus unknownNCT05220891
- Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.Status unknownNCT05218538
- A Model Based on Computed Tomography Imaging Parameters to Predict Poor Survival in Patients With Liver CirrhosisStatus unknownNCT05208736
- Cirrhotics Undergoing General SurgeryCompletedNCT05202457
- Liver Cancer Prevention Randomized Control TrialActive, not recruitingNCT05196867Not applicable
- To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.Status unknownNCT05187715Not applicable
- Natural Course and Prognosis of Hospitalized Patients With CirrhosisStatus unknownNCT05185154
- Utilization of MAsS in Patients Undergoing LT for HCCTerminatedNCT05184283
- Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With CirrhosisStatus unknownNCT05181332
- Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286CompletedNCT05180162Phase 1
- Composition for Treating Cirrhosis and Liver Cancer (SB-1121)CompletedNCT05178303Phase 4
- Development of Non-Invasive MRI Applications for Liver Fibrosis and InflammationCompletedNCT05168982
- Novel MRE Technique to Assess a Risk Factor for Liver CancerActive, not recruitingNCT05165446
- ROLE OF URINARY BIOMARKER NEUTROPHIL GELATINASE ASSOCIATED LIPOCALCIN (NGAL) IN EARLY PREDICTION OF AKI IN CIRRHOSIS OF LIVERCompletedNCT05161910
- Study of Decompensated Alcoholic Cirrhosis Treatment by Stem CellsStatus unknownNCT05155657Phase 1
- Three-Dimensional T1rho Using Spiral Fast Spin EchoWithdrawnNCT05154656
- T1rho Imaging of Liver in Presence of IronCompletedNCT05154643
- Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B PatientsActive, not recruitingNCT05147090Phase 4
- Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its ComplicationStatus unknownNCT05128305Phase 3
- Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced CoagulopathyCompletedNCT05124041Not applicable
- Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated CirrhosisStatus unknownNCT05121870Phase 2
- Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASHStatus unknownNCT05120557Not applicable
- Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.CompletedNCT05115942Phase 3
- Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver DiseaseCompletedNCT05107271
- Impact of Weight Loss in Cirrhosis With Obesity and MAFLDStatus unknownNCT05104541Not applicable
- To Study the Effects of Host Genetic Factors on Liver CirrhosisCompletedNCT05095181
- Prevention of HCC Using Mobile Phone ApplicationsStatus unknownNCT05094869
- Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.Status unknownNCT05093218Not applicable
- The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular CarcinomaStatus unknownNCT05088811
- Re-compensation and Its Clinical Characteristics in HBV Decompensated CirrhosisStatus unknownNCT05086536
- Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.WithdrawnNCT05084534Not applicable
- Observational Prospective Study.at the End of the Study the Patients Will be Classified According to PH,Serum Bicarbonate and Serum Sodium Into 6 Groups and Statistical Analysis Will be Performed Using SpssCompletedNCT05082064
- Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver CirrhosisCompletedNCT05080465Phase 3
- To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)Status unknownNCT05060523Not applicable
- Volume Resuscitation in Cirrhosis With Sepsis Induced HypotensionCompletedNCT05059795
- Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal VaricesCompletedNCT05057572Not applicable
- The Role of the Kidneys and Liver in the Elimination of GlucagonCompletedNCT05056584Not applicable
- A Randomized Controlled Study on the Treatment of Cirrhosis Combined With HypersplenismStatus unknownNCT05055713Not applicable
- Myocardial Fibrosis and Inflammation in Liver CirrhosisCompletedNCT05047029
- CirrhoCare in COVID-19: A Pilot, Remote, Home Monitoring Study in Advanced CirrhosisStatus unknownNCT05045924
- Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral SolutionActive, not recruitingNCT05044819Phase 4
- Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort StudyStatus unknownNCT05036031
- Feasibility of an App-based Nutrition & Exercise Program in CirrhosisCompletedNCT05033327Not applicable
- Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine RegimenStatus unknownNCT05028322Phase 2
- Extension Study of Carvedilol RCT StudyStatus unknownNCT05021406Not applicable
- Empagliflozin in Diuretic Refractory AscitesCompletedNCT05013502Phase 1
- Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis PatientsCompletedNCT05012501
- Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver FibrosisCompletedNCT05008263
- Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal HypertensionCompletedNCT04994548
- Comparing a Direct Versus an Indirect Approach to Measuring the Portalsytemic Pressure GradientsCompletedNCT04987034
- The Correlation Between Cirrhotic Cardiomyopathy and Perioperative Cardiovascular Events in Liver TransplantationStatus unknownNCT04976764
- Safety of Anticoagulant Therapy After Endoscopic TreatmentCompletedNCT04976543Phase 4
- Prevalence, Clinical Features and Risk Factors of Cirrhotic Cardiomyopathy Assessed by Two-dimensional Speckle Tracking ImagingStatus unknownNCT04969055
- Timing of Endoscopy for Acute Variceal Bleeding in Patients With CirrhosisCompletedNCT04957875
- Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)Status unknownNCT04956328Phase 3
- LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver DiseaseCompletedNCT04953143Not applicable
- Impact of Continuous Renal Replacement Therapy on Systemic Hemodynamics and Lactate Clearance in Critically Ill Cirrhotics With Septic Shock.Status unknownNCT04949178
- Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)Active, not recruitingNCT04939441Phase 4
- The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in CirrhosisStatus unknownNCT04932200
- Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan OperationStatus unknownNCT04908657Phase 4
- Sexual Dysfunction in Patients With Chronic Liver DiseaseStatus unknownNCT04896723
- Bariatric Endoscopy and NAFLDActive, not recruitingNCT04895943
- Initiation of Diet in Esophageal Varices After Ligation (IDEAL) StudyStatus unknownNCT04890210Not applicable
- A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and SarcopeniaCompletedNCT04874350Phase 2
- Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in CirrhosisCompletedNCT04867954
- Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Active, not recruitingNCT04863703
- Systemic Inflammation in Liver CirrhosisCompletedNCT04850534
- Avatrombopaq In Patients With CirrhosisStatus unknownNCT04845659Phase 4
- Fecal Microbiota Transplantation in Decompensated CirrhosisCompletedNCT04842539Not applicable
- Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated CirrhosisStatus unknownNCT04828512
- Efficacy and Safety of EUS-Guided Therapy Versus BRTO for Gastric Varices With ShuntCompletedNCT04828369
- Intraoperative Phlebotomies and Bleeding in Liver TransplantationCompletedNCT04826666
- The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver CirrhosisCompletedNCT04823780
- A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)Active, not recruitingNCT04820036Not applicable
- Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.Status unknownNCT04819568Not applicable
- Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.Status unknownNCT04816240Not applicable
- Single-dose PK Assessment of Oral Proglumide in Those With Hepatic ImpairmentCompletedNCT04814602Early Phase 1
- Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain DeathStatus unknownNCT04812054Not applicable
- Esophagectomy in Patients With Liver CirrhosisCompletedNCT04809870
- Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver CirrhosisStatus unknownNCT04794946Not applicable
- Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.CompletedNCT04791397Not applicable
- Acute-On-Chronic Liver Failure In Cirrhotic PatientsCompletedNCT04790435
- Mortality, Morbidity and Risk Factors of Liver RetransplantationCompletedNCT04789213
- Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic EncephalopathyCompletedNCT04787276Not applicable
- The vPPG-detecting Software Guided Management of Cirrhotic Portal HypertensionStatus unknownNCT04786782
- Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD PatientsCompletedNCT04785937Not applicable
- Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology ConsultationCompletedNCT04782050Not applicable
- Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLDCompletedNCT04774302
- The Effect of Induced Hyperammonaemia on Sleep and Melanopsin-mediated Pupillary Light Response in Patients With Liver CirrhosisCompletedNCT04771104Not applicable
- Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver CirrhosisCompletedNCT04763707
- Evaluation of Liver Fibrosis With 2D-Shear Wave ElastographyCompletedNCT04759521
- Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE ExaminationCompletedNCT04747457Not applicable
- The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.Status unknownNCT04727320Early Phase 1
- Prophylactic Antibiotics in Prevention of Spontaneous Bacterial Peritonitis in Compensated Liver CirrhosisStatus unknownNCT04711122
- Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.CompletedNCT04688034Phase 1
- Elective Umbilical Hernia Repair in Patients With CirrhosisStatus unknownNCT04687579Not applicable
- Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic CancersActive, not recruitingNCT04682847
- The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFFCompletedNCT04682600Not applicable